Latest Breaking News On - Teva europe commercial - Page 1 : vimarsana.com

MHRA today granted a licence for Ongavia (ranibizumab), a biosimilar to Lucentis , for the treatment of (wet) age-related macular degeneration (AMD) and several other eye diseases, such as diabetic

United kingdomFrankg holzPiotr oleksyFederico ricciJoachim kieferRichard daniellPeterk kaiserSteffen schmitz valckenbergJohn loweUnited kingdom medicines healthcare regulatory agencyPolpharma biologics groupStudy group efficacyGenentech incFormycon groupExperimental eye researchTeva pharmaceutical industries ltd